Update shared on29 Aug 2025
Fair value Increased 3.85%Despite a lower net profit margin, the significant rise in future P/E suggests improved earnings expectations or higher valuation multiples, resulting in a modest increase in the consensus analyst price target to HK$22.71.
What's in the News
- China Life Insurance to hold a Special/Extraordinary Shareholders Meeting on Sep 25, 2025.
- Board Meeting scheduled for Aug 27, 2025 to consider and approve interim results for the first half of 2025 and other business.
- Final dividend of RMB 0.45 per share (HKD 0.49286) approved for FY2024, with payment expected on Aug 21, 2025.
- Removed from Shanghai Stock Exchange 180 Value Index.
Valuation Changes
Summary of Valuation Changes for China Life Insurance
- The Consensus Analyst Price Target has risen slightly from HK$21.87 to HK$22.71.
- The Future P/E for China Life Insurance has significantly risen from 9.14x to 11.62x.
- The Net Profit Margin for China Life Insurance has fallen from 10.04% to 9.04%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.